These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6445106)

  • 1. On the nature of the antigen (HO-SAL) responsible for protection of August rats against a syngeneic leukemia following immunization with AgB-identical allogeneic cells.
    Alexander P; Denham S; Hooton J
    Transplant Proc; 1980 Mar; 12(1):152-5. PubMed ID: 6445106
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of transplantable tumors by adoptive transfer of spleen cells from immunized rats.
    Fish DC; Djurickovic DB; Huebner RJ
    J Immunol; 1979 Dec; 123(6):2658-63. PubMed ID: 501086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft-vs-leukemia and moderation of graft-vs-host reaction in transplantation therapy of viral leukemia.
    Okunewick JP; Meredith RF; Raikow RB; Brozovich BJ; Magliere K
    Exp Hematol; 1981 Aug; 9(7):754-65. PubMed ID: 7032959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
    Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
    Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response-associated antigens on mouse leukemia cells. II. Anti-Ia sera inhibit the MLR reaction between normal GR spleen cells and syngeneic spleen cells of GRSL tumor-bearing mice.
    Okuda K; Neely BC; Hilgers J; David CS
    Transplantation; 1978 Nov; 26(5):300-3. PubMed ID: 151953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can hamsters suppress allogeneic responsiveness?
    Lause DB; Streilein JW
    Fed Proc; 1978 May; 37(7):2050-1. PubMed ID: 25200
    [No Abstract]   [Full Text] [Related]  

  • 7. A schema for immunotherapy.
    Bach FH; Bach ML; Zoschke DC
    Bibl Haematol; 1973; 39():910-5. PubMed ID: 4149724
    [No Abstract]   [Full Text] [Related]  

  • 8. The genetics of the graft-versus-host reactions in rats: strength of reaction against RT1.A and RT1.B antigens alone and in combination.
    Butcher GW; Licence DR; Roser BJ
    Transplant Proc; 1981 Jun; 13(2):1375-7. PubMed ID: 6454284
    [No Abstract]   [Full Text] [Related]  

  • 9. Protection against graft-versus-host disease by large doses of donor CD4+ T cells: a novel approach to bone marrow transplantation.
    Heath WR; Miller JF; Sprent J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1222-4. PubMed ID: 8442095
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppression of the graft-versus-host reaction by passive immunization of donor against recipient antigens.
    Safford JW; Tokuda S
    Proc Soc Exp Biol Med; 1970 Feb; 133(2):651-4. PubMed ID: 4391839
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative studies on graft-versus-leukemia after allogeneic bone marrow transplantation in rat models for acute myelocytic and lymphocytic leukemia.
    Kloosterman TC; Tielemans MJ; Martens AC; van Bekkum DW; Hagenbeek A
    Bone Marrow Transplant; 1994 Jul; 14(1):15-22. PubMed ID: 7951103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological concepts relating to organ transplantation].
    Dei Poli G; Massa G; Rosso PA; Dei Poli N
    Minerva Chir; 1980 Jun; 35(11):829-78. PubMed ID: 6450338
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic fine structure of the H-2 gene complex.
    Shreffler DC
    Soc Gen Physiol Ser; 1974; 29():83-100. PubMed ID: 4154504
    [No Abstract]   [Full Text] [Related]  

  • 14. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
    Cohen P; Vourka-Karussis U; Weiss L; Slavin S
    J Immunol; 1993 Nov; 151(9):4803-10. PubMed ID: 8409438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradication of residual disease by administration of leukemia-specific T cells after experimental allogeneic bone marrow transplantation.
    Zeis M; Uharek L; Glass B; Vosskötter W; Dreger P; Schmitz N; Steinmann J
    Exp Hematol; 1998 Oct; 26(11):1068-73. PubMed ID: 9766447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of T-cell responses to histocompatibility antigens by BCG pre-treatment.
    Orbach-Arbouys S; Castes M
    Immunology; 1980 Feb; 39(2):263-8. PubMed ID: 6445869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft-versus-myeloid leukemia responses following syngeneic and allogeneic bone marrow transplantation.
    Korngold R; Leighton C; Manser T
    Transplantation; 1994 Aug; 58(3):278-87. PubMed ID: 7914387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV; Pettey CL; Collins JJ
    Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat alloantibody responses against strong and weak histocompatibility antigens.
    Miller C; DeWitt C
    J Immunol; 1972 Nov; 109(5):919-26. PubMed ID: 5079095
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism by which antibodies to non-AgB antigens mediate rejection of rat leukaemia cells.
    Denham S; Hooton JW; Barfoot RK; Alexander P; Mayol R; Wrathmell AB
    Br J Cancer; 1980 Sep; 42(3):408-15. PubMed ID: 7426344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.